Ranbaxy to pay $40 million to settle Texas probe on drug pricing

Ranbaxy has settled the charges with the state authority with a payment of around $40 million. The Texas investigation was related to the manner in which Ranbaxy has historically reported pricing data to Texas Medicaid for certain drugs.